You have 9 free searches left this month | to do more

azd4877

Azd4877 is a drug used to treat Lymphoma, Acute Myelogenous Leukemia, Bladder Cancer, and other conditions. Azd4877 is not being actively studied and prior, has been studied in 3.

Top SponsorsTop SitesTop Investigators
AstraZenecaResearch Site
Research site
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
A
Phase I, Open-label, Dose Escalation of AZD4877 in Hematologic Malignancies - 2007
Terminated
  • Lymphoma
  • AZD4877
  • Buffalo, New York
  • +2 more
2011-01-24
Jan 24, 2011
A
Phase I/II, Open-label, Multi-center, Two Part Dose-escalation, Safety, Pharmacokinetics (PK) and Efficacy Study of AZD4877 in Patients With Acute Myelogenous Leukemia (AML) - 2009
Terminated
Has Results
  • Acute Myelogenous Leukemia
  • AZD4877
  • Chicago, Illinois
  • +3 more
2010-12-07
Dec 7, 2010
A
A Phase II Study of AZD4877 (a Novel Anti-mitotic Agent) in Advanced Bladder Cancer - 2009
Completed
Has Results
  • Bladder Cancer
  • +4 more
  • AZD4877
  • Palo Alto, California
  • +35 more
2010-12-13
Dec 13, 2010
A
Phase I, Open-label, Dose-escalation, Safety and PK Study of AZD4877 - 2008
Terminated
  • Lymphoma
  • +2 more
  • AZD4877
  • New York, New York
  • +2 more
2009-09-23
Sep 23, 2009
A
A Phase I, Dose-Escalation Study to Assess the Safety and Drug Levels in Blood of AZD4877 in Japanese Adult Patients - 2009
Completed
  • Cancer
  • +2 more
  • AZD4877
  • Fukuoka, Japan
    Research Site
2009-07-20
Jul 20, 2009
A
Phase I, Open-Label, Dose-Escalation Study of AZD4877 in Solid Tumors - 2008
Completed
  • Neoplasms
  • AZD4877
  • Denver, Colorado
  • +2 more
2009-04-30
Apr 30, 2009